Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
enGene Holdings Inc. stock logo
ENGN
enGene
$1.76
-1.7%		$1.77
$1.40
▼
$12.25
$119.90M-0.28965,272 shs731,178 shs
ProKidney Corp. stock logo
PROK
ProKidney
$1.58
+2.6%		$1.74
$1.45
▼
$3.55
$465.17M1.611.08 million shs662,209 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$5.76
+3.8%		$5.45
$2.92
▼
$6.77
$465.62M0.96305,253 shs182,401 shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$4.20
+5.3%		$4.69
$3.67
▼
$23.20
$465.03M1.894.11 million shs7.84 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
enGene Holdings Inc. stock logo
ENGN
enGene
-1.68%-6.88%+1.73%-75.79%-49.71%
ProKidney Corp. stock logo
PROK
ProKidney
+2.60%+3.95%-22.55%-16.84%-41.26%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
+3.78%-4.79%-0.17%+10.34%+81.13%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+5.26%+5.26%-6.46%-32.69%-31.42%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
enGene Holdings Inc. stock logo
ENGN
enGene
$1.76
-1.7%		$1.77
$1.40
▼
$12.25
$119.90M-0.28965,272 shs731,178 shs
ProKidney Corp. stock logo
PROK
ProKidney
$1.58
+2.6%		$1.74
$1.45
▼
$3.55
$465.17M1.611.08 million shs662,209 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$5.76
+3.8%		$5.45
$2.92
▼
$6.77
$465.62M0.96305,253 shs182,401 shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$4.20
+5.3%		$4.69
$3.67
▼
$23.20
$465.03M1.894.11 million shs7.84 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
enGene Holdings Inc. stock logo
ENGN
enGene
-1.68%-6.88%+1.73%-75.79%-49.71%
ProKidney Corp. stock logo
PROK
ProKidney
+2.60%+3.95%-22.55%-16.84%-41.26%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
+3.78%-4.79%-0.17%+10.34%+81.13%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+5.26%+5.26%-6.46%-32.69%-31.42%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
enGene Holdings Inc. stock logo
ENGN
enGene
2.14
Hold$11.05527.58% Upside
ProKidney Corp. stock logo
PROK
ProKidney
2.50
Moderate Buy$12.00659.49% Upside
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.40
Hold$9.0056.25% Upside
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.29
Hold$11.00161.90% Upside

Current Analyst Ratings Breakdown

Latest ENGN, TLRY, SOPH, and PROK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/21/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/20/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$12.00
7/17/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/14/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$7.00 ➝ $5.00
7/10/2026
ProKidney Corp. stock logo
PROK
ProKidney
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/25/2026
ProKidney Corp. stock logo
PROK
ProKidney
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/18/2026
enGene Holdings Inc. stock logo
ENGN
enGene
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeEqual Weight ➝ Underweight$3.00
6/16/2026
enGene Holdings Inc. stock logo
ENGN
enGene
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$6.00 ➝ $4.00
6/15/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$8.00
5/18/2026
ProKidney Corp. stock logo
PROK
ProKidney
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$12.00
5/15/2026
enGene Holdings Inc. stock logo
ENGN
enGene
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
enGene Holdings Inc. stock logo
ENGN
enGene
N/AN/AN/AN/A$2.60 per shareN/A
ProKidney Corp. stock logo
PROK
ProKidney
$890K536.24N/AN/A($3.36) per share-0.47
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$77.27M6.25N/AN/A$0.69 per share8.35
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$915.45M0.53$1.52 per share2.76$13.68 per share0.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
enGene Holdings Inc. stock logo
ENGN
enGene
-$117.30M-$2.17N/AN/AN/AN/A-56.06%-45.64%9/14/2026 (Estimated)
ProKidney Corp. stock logo
PROK
ProKidney
-$68.99M-$0.53N/AN/AN/A-8,131.50%N/A-21.39%8/11/2026 (Estimated)
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$79M-$0.52N/AN/AN/A-44.48%-62.74%-21.85%8/4/2026 (Estimated)
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$2.19B-$1.08N/A42.00N/A-13.11%-7.76%-5.59%10/8/2026 (Estimated)

Latest ENGN, TLRY, SOPH, and PROK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
ProKidney Corp. stock logo
PROK
ProKidney
-$0.13N/AN/AN/A$0.19 millionN/A
8/4/2026Q2 2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.21N/AN/AN/A$21.72 millionN/A
7/28/2026Q4 2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.0120-$0.43-$0.4180-$0.43$246.30 million$281.71 million
6/15/2026Q2 2026
enGene Holdings Inc. stock logo
ENGN
enGene
-$0.48-$0.43+$0.05-$0.43N/AN/A
5/15/2026Q1 2026
ProKidney Corp. stock logo
PROK
ProKidney
-$0.13-$0.14-$0.01-$0.14$0.10 million$0.23 million
5/5/2026Q1 2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.2325-$0.27-$0.0375-$0.27$20.40 million$21.69 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
enGene Holdings Inc. stock logo
ENGN
enGene
$1.5889.83%N/AN/A N/A
ProKidney Corp. stock logo
PROK
ProKidney
N/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
enGene Holdings Inc. stock logo
ENGN
enGene
0.10
12.57
12.57
ProKidney Corp. stock logo
PROK
ProKidney
N/A
9.06
9.06
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
1.05
2.06
1.90
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.22
2.21
1.66

Institutional Ownership

CompanyInstitutional Ownership
enGene Holdings Inc. stock logo
ENGN
enGene
64.16%
ProKidney Corp. stock logo
PROK
ProKidney
51.59%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%

Insider Ownership

CompanyInsider Ownership
enGene Holdings Inc. stock logo
ENGN
enGene
10.50%
ProKidney Corp. stock logo
PROK
ProKidney
39.83%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4.88%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
enGene Holdings Inc. stock logo
ENGN
enGene
3166.99 million59.95 millionN/A
ProKidney Corp. stock logo
PROK
ProKidney
3302.06 million181.75 millionOptionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
52083.89 million79.80 millionNot Optionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2,842116.55 million115.57 millionOptionable

Recent News About These Companies

Tilray Brands seen creating long-term value through diversified platform, Jefferies says
July 30 at 7:40 PM  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1096317/tilray-brands-seen-creating-long-term-value-through-diversified-platform-jefferies-says-1096317.html
Tilray Brands (NASDAQ:TLRY) Stock Price Up 5.3% - Should You Buy?
July 30 at 5:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-stock-price-up-53-should-you-buy-2026-07-30/
Tilray Brands seen creating long-term value through diversified platform, Jefferies says
July 30 at 3:13 PM  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1096317?snapi
Cannabis Stocks To Follow Today - July 30th
July 30 at 12:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/cannabis-stocks-to-follow-today-july-30th-2026-07-30/
Tilray Brands stock continues its downward spiral: buy the dip or sell the rip?
July 30 at 12:00 PM  |  invezz.comI
Tilray Q4: Dilution Outweighs Progress
July 29 at 3:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4927118-tilray-q4-dilution-outweighs-progress
3 Canadian Marijuana Stocks Can Make You Big Gains
July 29 at 12:12 PM  |  marijuanastocks.comM
Tilray Brands (NASDAQ:TLRY) Announces Quarterly Earnings Results
July 29 at 10:55 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-announces-quarterly-earnings-results-2026-07-29/
Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and ...
July 29 at 8:44 AM  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/tilray-brands-delivers-record-fiscal-200500048.html
Tilray Brands (NASDAQ:TLRY) Draws Attention After Fresh Market Update
July 29 at 8:44 AM  |  kalkinemedia.comK
Tilray projects $68M-$75M adjusted EBITDA in fiscal 2027 as it targets margin expansion
July 29 at 8:44 AM  |  seekingalpha.comhttps://seekingalpha.com/news/4620062-tilray-projects-68m-75m-adjusted-ebitda-in-fiscal-2027-as-it-targets-margin-expansion
Tilray Brands (TLRY) stock is trending: Here's what you should know
July 29 at 8:44 AM  |  msn.comhttps://www.msn.com/en-us/money/news/tilray-brands-tlry-stock-is-trending-heres-what-you-should-know/ar-AA28WTaO
Tilray Brands Inc (TLRY) Q4 2026 Earnings Call Highlights: Record Revenue and Strategic ...
July 29 at 8:44 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tilray-brands-inc-tlry-q4-050157811.html
Tilray Brands Inc (TLRY) Q4 2026 Earnings Call Highlights: Record Revenue and Strategic ...
July 29 at 8:44 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tilray-brands-inc-tlry-q4-050157811.html
Tilray Brands, Inc. (TLRY) Q4 2026 Earnings Call Transcript
July 29 at 5:00 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4926722-tilray-brands-inc-tlry-q4-2026-earnings-call-transcript
Tilray Brands, Inc. (TLRY) Reports Q4 Loss, Beats Revenue Estimates
July 28 at 12:15 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tilray-brands-inc-tlry-reports-233003338.html
Tilray Brands, Inc. (TLRY) Reports Q4 Loss, Beats Revenue Estimates
July 28 at 8:30 PM  |  zacks.comhttps://www.zacks.com/stock/news/2962668/tilray-brands-inc-tlry-reports-q4-loss-beats-revenue-estimates?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_4-2962668
Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness
July 28 at 7:14 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tilray-brands-delivers-record-fiscal-200500048.html
Tilray Brands Q4 Earnings Call Highlights
July 28 at 7:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tilray-brands-q4-earnings-call-highlights-2026-07-28/
Tilray Brands (TLRY) Releases Q4 2026 Earnings: Revenue Growth but EPS Miss
July 28 at 4:50 PM  |  quiverquant.comQ
Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness
July 28 at 4:05 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334721/0/en/tilray-brands-delivers-record-fiscal-2026-revenue-and-adjusted-ebitda-demonstrating-the-strength-of-its-diversified-global-platform-across-cannabis-beverage-hospitality-and-wellnes.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

enGene stock logo

enGene NASDAQ:ENGN

$1.76 -0.03 (-1.68%)
Closing price 07/30/2026 04:00 PM Eastern
Extended Trading
$1.77 +0.01 (+0.57%)
As of 07/30/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

ProKidney stock logo

ProKidney NASDAQ:PROK

$1.58 +0.04 (+2.60%)
Closing price 07/30/2026 04:00 PM Eastern
Extended Trading
$1.59 +0.01 (+0.70%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.

SOPHiA GENETICS stock logo

SOPHiA GENETICS NASDAQ:SOPH

$5.76 +0.21 (+3.78%)
Closing price 07/30/2026 04:00 PM Eastern
Extended Trading
$5.89 +0.13 (+2.33%)
As of 05:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$4.20 +0.21 (+5.26%)
Closing price 07/30/2026 04:00 PM Eastern
Extended Trading
$4.22 +0.02 (+0.57%)
As of 07:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas